Skip to content
Disclosery

EXANE DERIVATIVES: KBR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on KBR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 8,442 KBR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 8,442 shares
    Change vs previous 13F -658 shares

    0.23% of the 13F portfolio, value $408,425.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 9,100 shares
    Change vs previous 13F -4,021 shares

    0.14% of the 13F portfolio, value $498,012.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 13,121 shares
    Change vs previous 13F -530 shares

    0.15% of the 13F portfolio, value $624,799.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 13,651 shares
    Change vs previous 13F +7,653 shares

    0.13% of the 13F portfolio, value $537,830.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 5,998 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $233,797.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).